Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edrecolomab vs No Adjuvant Therapy in Stage II Colon Cancer
NCT00002968Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- May 1997
- Primary completion
- Jul 2003
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of edrecolomab in colon cancer, sponsored by National Cancer Institute. Started May 1997; status: completed.
02
Drugs
edrecolomab
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT00002968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002968.